Skip to main content

Type 2 diabetes - a membrane trafficking disease?


I heard a great talk yesterday by Dr. Patrik Rorsman from the University of Oxford, who has a new way of thinking about type 2 diabetes. He believes some individuals who develop the disease may have a deficit in insulin exocytosis, but not by the mechanism that anyone would have predicted.
It is abundantly clear that type-2 diabetes is not caused by a lack of available insulin in the pancreas. Therefore, Dr. Rorsman hypothesized that the mechanism of exocytic release of insulin may be perturbed in diabetic patients. However, when he made classical measurements to detect exocytic release in primary tissues, such as amperometry of cargo release and monitoring membrane capacitance, he saw no differences between healthy and diseased cells. It wasn’t until he engineered an elegant ATP-sensitive, feedback biosensor into his recording set-up that he detected a difference in exocytosis.
What he found suggests that the equilibrium between kiss-and-run and full-fusion exocytic events is slightly perturbed in diabetic tissue, such that insulin-containing granules are a little bit less likely to fully fuse with the membrane and release all their cargo. During the kiss-and-run events, the neck of the fusing granule acts as a sieve and prevents insulin from leaking out. The overall effect of too many kiss-and-run events then is reduced insulin release and decreased glucose sensitivity.
Furthermore, he found that this subtle change in exocytic equilibrium in beta cells correlates very well with the expression of Sox4, a transcription factor identified in a screen of tissues from hundreds of patients, both diabetic and healthy. Sox4 regulates Amisyn, a syntaxin-6 binding protein that appears to compete with normal SNAREs to inhibit full granule fusion. Amycin correlated with increased resting blood glucose levels and decreased insulin release in the patient screen as well, further implying a link to its role in granule exocytosis.
Dr. Rorsman is interested now in targeting this pathway to correct the balance of exocytic events in the pancreas and restore glucose sensitivity to diabetic tissue, and he already has some therapeutic ideas. He also believes Sox4 expression is likely misregulated in a subset of diabetic individuals and we should pay attention to it as a potential biomarker for development of the disease. It will be interesting to know whether some genotypes are more susceptible to Sox4 misregulation, or if lifestyle also plays a role in its expression.




Labels:

Comments

Post a Comment

Popular posts from this blog

AlphaFold2 Part 2: The ion channel challenge

Last month I wrote about the wonders and perils of the artificial intelligence program that predicts 3D protein structures, AlphaFold2. As an ion channel enthusiast , I naturally wanted to know how AlphaFold2 performs at predicting the structures of proteins embedded in cell membranes. When I search PubMed for articles that mention both "AlphaFold" and "ion channel" I only get 34 hits. This surprised me, given the hype and the general paranoia around AI replacing humanity. If we use these search results as a proxy for the state of the ion channel protein structure prediction field, I'd say the juice is still in the coconut. I wanted to know how well AF2 would do at predicting an ion channel protein structure, so I asked it to generate the structure of Kv2.1, a voltage-gated potassium ion channel that I studied during graduate school. Kv2.1 is a pretty important protein. It regulates neuron firing throughout the brain and body where it helps us learn new stuff, ...
Post a Comment
Read more

Precision murder -- wait, no -- medicine

A non-zero amount of what we call ‘medicine’ could be described as just controlled cell murder.  This was my revelation after researching a new treatment for certain cardiac arrhythmias called Pulsed Electric Field Ablation, which I became interested in when my father-in-law asked me how it worked during our Christmas visit. “How can it kill the heart cells and leave the nerves and blood vessels intact?” I had no idea. I know next-to-nothing about medical treatments for cardiac patients, much less how this Pulsed Field Ablation technique could have fewer side effects than the standard-of-care ablation techniques. A quick Google search piqued my curiosity when I learned that PFA is also sometimes called “high frequency irreversible electroporation”. While less catchy, that name revealed a bit more about the mechanism of action behind PFA - electroporation - which happens to be something I actually do know something about. Electroporation refers to the formation of holes (pores) in c...
Post a Comment
Read more

iPSCs, the new model organism?

Induced pluripotent stem cells. The name doesn't exactly roll off the tongue and it certainly doesn't conjure images of mice, fruit flies, monkeys, or any of the other classic model organisms used for basic biomedical research. These so called "model organisms" are just that; animals that help scientists model the way that the most promising human therapeutics in the collective pipeline will behave in humans. And now induced pluripotent stem cells, or iPSCs, are becoming an increasingly popular tool used for developing and testing novel drugs way before we expose any real human patients to them. The upside to using model organisms is pretty obvious -- we minimize exposure of humans to potentially unsafe molecules. The downsides are many, but one big one is that sometimes potential new drug molecules look really promising when they are given to a mouse with a human-like disease, but then that same molecule does nothing (or worse, is toxic!) when it goes into human clin...
Post a Comment
Read more